These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31771971)

  • 1. Sickle cell disease and thalassaemia antenatal screening programme in England over 10 years: a review from 2007/2008 to 2016/2017.
    Weil LG; Charlton MR; Coppinger C; Daniel Y; Streetly A
    J Clin Pathol; 2020 Apr; 73(4):183-190. PubMed ID: 31771971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial.
    Dormandy E; Gulliford M; Bryan S; Roberts TE; Calnan M; Atkin K; Karnon J; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Tsianakas V; Jones P; Marteau TM
    BMJ; 2010 Oct; 341():c5132. PubMed ID: 20923841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric analysis of unknown haemoglobin fractions identified by high-performance liquid chromatography in an antenatal screening programme.
    Griffin M; Eyre J; Dack S; Wright J
    J Clin Pathol; 2015 May; 68(5):388-90. PubMed ID: 25694443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial.
    Dormandy E; Bryan S; Gulliford MC; Roberts TE; Ades AE; Calnan M; Atkin K; Karnon J; Barton PM; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Davis V; Brown K; Juarez-Garcia A; Tsianakas V; Marteau TM
    Health Technol Assess; 2010 Apr; 14(20):1-160. PubMed ID: 20416236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delay between pregnancy confirmation and sickle cell and [corrected] thalassaemia screening: a population-based cohort study.
    Dormandy E; Gulliford MC; Reid EP; Brown K; Marteau TM;
    Br J Gen Pract; 2008 Mar; 58(548):154-9. PubMed ID: 18318968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal screening for haemoglobinopathies: current status, barriers and ethics.
    Chakravorty S; Dick MC
    Br J Haematol; 2019 Nov; 187(4):431-440. PubMed ID: 31509241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of GPs' experiences.
    Tsianakas V; Calnan M; Atkin K; Dormandy E; Marteau TM
    Br J Gen Pract; 2010 Nov; 60(580):822-8. PubMed ID: 21062549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants.
    Theodoridou S; Prapas N; Balassopoulou A; Boutou E; Vyzantiadis TA; Adamidou D; Delaki EE; Yfanti E; Economou M; Teli Α; Karakasidou O; Skatharoudi E; Theodoridis T; Voskaridou E
    Hemoglobin; 2018 Jul; 42(4):257-263. PubMed ID: 30501529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
    Bain BJ; Daniel Y; Henthorn J; de la Salle B; Hogan A; Roy NBA; Mooney C; Langabeer L; Rees DC;
    Br J Haematol; 2023 Jun; 201(6):1047-1065. PubMed ID: 37271570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact on informed choice of offering antenatal sickle cell and thalassaemia screening in primary care: a randomized trial.
    Brown K; Dormandy E; Reid E; Gulliford M; Marteau T
    J Med Screen; 2011; 18(2):65-75. PubMed ID: 21852698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research.
    Davies SC; Cronin E; Gill M; Greengross P; Hickman M; Normand C
    Health Technol Assess; 2000; 4(3):i-v, 1-99. PubMed ID: 10840658
    [No Abstract]   [Full Text] [Related]  

  • 12. Offering antenatal sickle cell and thalassaemia screening in primary care: a pre-post evaluation of a brief type of communication skills training.
    Dormandy E; Reid E; Tsianakas V; O'Neil B; Gill E; Marteau TM
    Patient Educ Couns; 2012 Oct; 89(1):129-33. PubMed ID: 22742984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey on knowledge, attitude, acceptance and related factors among pregnant women in Thailand regarding antenatal thalassaemia screening.
    Hanprasertpong T; Raungrongmorakot K; Geater A; Puapornpong P; Laosooksathit W; Hemachandra A; Suksamarnwong M
    J Obstet Gynaecol; 2018 Oct; 38(7):950-955. PubMed ID: 29565194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of women's experiences and expectations of participation.
    Tsianakas V; Atkin K; Calnan MW; Dormandy E; Marteau TM
    Health Expect; 2012 Jun; 15(2):115-25. PubMed ID: 21366810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for sickle cell and thalassaemia in primary care: a cost-effectiveness study.
    Bryan S; Dormandy E; Roberts T; Ades A; Barton P; Juarez-Garcia A; Andronis L; Karnon J; Marteau TM
    Br J Gen Pract; 2011 Oct; 61(591):e620-7. PubMed ID: 22152833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is routine molecular screening for common alpha-thalassaemia deletions necessary as part of an antenatal screening programme?
    Sorour Y; Heppinstall S; Porter N; Wilson GA; Goodeve AC; Rees D; Wright J
    J Med Screen; 2007; 14(2):60-1. PubMed ID: 17626702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counselling for prenatal diagnosis of sickle cell disease and beta thalassaemia major: a four year experience.
    Anionwu EN; Patel N; Kanji G; Renges H; Brozović M
    J Med Genet; 1988 Nov; 25(11):769-72. PubMed ID: 3236357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
    Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
    J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic carrier screening for hemoglobinopathies: the situation in the Netherlands compared with England].
    van Rhee MA; Holm JP; Niermeijer MF
    Ned Tijdschr Geneeskd; 1998 May; 142(18):996-7. PubMed ID: 9623197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of universal antenatal screening for haemoglobinopathies.
    Greengross P; Hickman M; Gill M; Dugan B; Davies SC
    J Med Screen; 1999; 6(1):3-10. PubMed ID: 10321363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.